Save information for later
Sign Up

Learn About T-Cell Lymphoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top T-Cell Lymphoma Local Doctors?
Christiane S. Querfeld
Elite in T-Cell Lymphoma
Elite in T-Cell Lymphoma

City Of Hope Medical Foundation

1601 Avocado Ave, 
Newport Beach, CA 
Languages Spoken:
English
Offers Telehealth

Christiane Querfeld is a Dermatologist in Newport Beach, California. Dr. Querfeld and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Enrica Marchi
Elite in T-Cell Lymphoma
Oncology | Hematology
Elite in T-Cell Lymphoma
Oncology | Hematology

University Of Virginia Physicians Group

1240 Lee St, 
Charlottesville, VA 
Languages Spoken:
English, Italian
Accepting New Patients
Offers Telehealth

Enrica Marchi is an Oncologist and a Hematologist in Charlottesville, Virginia. Dr. Marchi and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Anaplastic Large Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Marchi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in T-Cell Lymphoma
Hematology | Hematology Oncology
Elite in T-Cell Lymphoma
Hematology | Hematology Oncology

City Of Hope Medical Foundation

1601 Avocado Ave, 
Newport Beach, CA 
Languages Spoken:
English

Jasmine Zain is a Hematologist and a Hematologist Oncology provider in Newport Beach, California. Dr. Zain and is rated as an Elite provider by MediFind in the treatment of T-Cell Lymphoma. Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

What are the latest T-Cell Lymphoma Clinical Trials?
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of ITK Inhibitor Soquelitinib Versus Physician's Choice Standard of Care Treatment (Selected Single Agent) in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Summary: A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of soquelitinib versus physician's choice standard of care (SOC) treatment (selected single agents) in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas (FHTCLs), or systemic anaplastic large-cell lymphoma (sALCL).

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma

Summary: DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractory diffuse large B cell lymphoma (DLBCL) after receiving at least two lines of therapy. Additional cohorts include subjects with B-cell primary or secondary central nervous system (CNS) lymphoma (PCNSL...